A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
National Cancer Institute, Egypt
BioNTech SE
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
University of Pittsburgh
National Cancer Centre, Singapore
AVEO Pharmaceuticals, Inc.
USWM, LLC (dba US WorldMeds)
Conjupro Biotherapeutics, Inc.
Pfizer
Aulos Bioscience, Inc.
Hoffmann-La Roche
Erasca, Inc.
Eli Lilly and Company
GlaxoSmithKline
Regeneron Pharmaceuticals
Mayo Clinic
Stanford University
PMV Pharmaceuticals, Inc
Mayo Clinic
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Pfizer
Pfizer
Tizona Therapeutics, Inc
Tasca Therapeutics
ALX Oncology Inc.
Clasp Therapeutics, Inc.
University of California, San Diego
OHSU Knight Cancer Institute
MacroGenics
Adaptimmune
University of California, San Diego
Solve Therapeutics
Kidney Cancer Research Bureau
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
University Health Network, Toronto
University Health Network, Toronto
University of Pittsburgh
M.D. Anderson Cancer Center
Pierre Fabre Medicament
OncoNano Medicine, Inc.